274 related articles for article (PubMed ID: 15160405)
1. Cure fraction estimation from the mixture cure models for grouped survival data.
Yu B; Tiwari RC; Cronin KA; Feuer EJ
Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
[TBL] [Abstract][Full Text] [Related]
2. CANSURV: A Windows program for population-based cancer survival analysis.
Yu B; Tiwari RC; Cronin KA; McDonald C; Feuer EJ
Comput Methods Programs Biomed; 2005 Dec; 80(3):195-203. PubMed ID: 16257080
[TBL] [Abstract][Full Text] [Related]
3. Estimation method of the semiparametric mixture cure gamma frailty model.
Peng Y; Zhang J
Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
[TBL] [Abstract][Full Text] [Related]
4. Estimating and modeling the cure fraction in population-based cancer survival analysis.
Lambert PC; Thompson JR; Weston CL; Dickman PW
Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
[TBL] [Abstract][Full Text] [Related]
5. A SAS macro for parametric and semiparametric mixture cure models.
Corbière F; Joly P
Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
[TBL] [Abstract][Full Text] [Related]
6. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
[TBL] [Abstract][Full Text] [Related]
7. A new estimation method for the semiparametric accelerated failure time mixture cure model.
Zhang J; Peng Y
Stat Med; 2007 Jul; 26(16):3157-71. PubMed ID: 17094075
[TBL] [Abstract][Full Text] [Related]
8. Multilevel mixture cure models with random effects.
Lai X; Yau KK
Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
[TBL] [Abstract][Full Text] [Related]
9. Cure rate model with interval censored data.
Kim YJ; Jhun M
Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
[TBL] [Abstract][Full Text] [Related]
10. Cure fraction model with random effects for regional variation in cancer survival.
Seppä K; Hakulinen T; Kim HJ; Läärä E
Stat Med; 2010 Nov; 29(27):2781-93. PubMed ID: 20862662
[TBL] [Abstract][Full Text] [Related]
11. Discrete-time survival models with long-term survivors.
Zhao X; Zhou X
Stat Med; 2008 Apr; 27(8):1261-81. PubMed ID: 17676708
[TBL] [Abstract][Full Text] [Related]
12. Long-term survivor mixture model with random effects: application to a multi-centre clinical trial of carcinoma.
Yau KK; Ng AS
Stat Med; 2001 Jun; 20(11):1591-607. PubMed ID: 11391690
[TBL] [Abstract][Full Text] [Related]
13. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V
BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508
[TBL] [Abstract][Full Text] [Related]
14. Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.
Pantazis N; Touloumi G
Stat Med; 2007 Dec; 26(30):5473-85. PubMed ID: 18058854
[TBL] [Abstract][Full Text] [Related]
15. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.
Hsu L; Gorfine M; Malone K
Stat Med; 2007 Nov; 26(25):4657-78. PubMed ID: 17348081
[TBL] [Abstract][Full Text] [Related]
16. The cure fraction of glioblastoma multiforme.
Smoll NR; Schaller K; Gautschi OP
Neuroepidemiology; 2012; 39(1):63-9. PubMed ID: 22776797
[TBL] [Abstract][Full Text] [Related]
17. The cure of cancer: a European perspective.
Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
[TBL] [Abstract][Full Text] [Related]
18. Utilization of a Mixture Cure Rate Model based on the Generalized Modified Weibull Distribution for the Analysis of Leukemia Patients.
Omer ME; Abu Bakar M; Adam M; Mustafa M
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1045-1053. PubMed ID: 33906295
[TBL] [Abstract][Full Text] [Related]
19. REML estimation for survival models with frailty.
McGilchrist CA
Biometrics; 1993 Mar; 49(1):221-5. PubMed ID: 8513103
[TBL] [Abstract][Full Text] [Related]
20. Bayesian transformation cure frailty models with multivariate failure time data.
Yin G
Stat Med; 2008 Dec; 27(28):5929-40. PubMed ID: 18618427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
